VEGF-C alters barrier function of cultured lymphatic endothelial cells through a VEGFR-3-dependent mechanism

Lymphatic Research and Biology

Volumn 5, Issue 2, 2007, Pages 105-113

  Breslin, Jerome W ^a   Yuan, Sarah Y ^a   Wu, Mack H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT PROTEIN; RECOMBINANT VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN C; VASCULOTROPIN RECEPTOR 3;

ADULT; ARTICLE; CELL CULTURE; DERMIS; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; LYMPH VESSEL; MICROCIRCULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL VEIN; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

ADULT; CELLS, CULTURED; CHEMOKINES; ENDOTHELIAL CELLS; ENDOTHELIUM, LYMPHATIC; ENDOTHELIUM, VASCULAR; HUMANS; UMBILICAL VEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

EID: 35348842901     PISSN: 15396851     EISSN: None     Source Type: Journal    
DOI: 10.1089/lrb.2007.1004     Document Type: Article

References (40)

1. Adair TH, Guyton AC. Lymph formation and its modification in the lymphatic system. In: Johnston MG, ed. Experimental Biology of the Lymphatic Circulation. New York: Elsevier; 1985:13-44.
2. Schmid-Schonbein GW. The second valve system in lymphatics. Lymphat Res Biol. 2003;1:25-9; discussion 9-31.
3. Mendoza E, Schmid-Schonbein GW. A model for mechanics of primary lymphatic valves. J Biomech Eng. 2003;125:407-14.
4. Trzewik J, Mallipattu SK, Artmann GM, Delano FA, Schmid-Schonbein GW. Evidence for a second valve system in lymphatics: endothelial microvalves. Faseb J. 2001;15:1711-7.
5. Yuan SY. Signal transduction pathways in enhanced microvascular permeability. Microcirculation. 2000;7: 395-403.
6. Huxley VH, Rumbaut RE. The microvasculature as a dynamic regulator of volume and solute exchange. Clin Exp Pharmacol Physiol. 2000;27:847-54.
7. Michel CC, Curry FE. Microvascular permeability. Physiol Rev. 1999;79:703-61.
8. Breslin JW, Pappas PJ, Cerveira JJ, Hobson RW, 2nd, Duran WN. VEGF Increases Endothelial Permeability by Separate Signaling Pathways Involving ERK-1/2 and Nitric Oxide. Am J Physiol Heart Circ Physiol. 2003; 284:H92-100.
9. Breslin JW, Sun H, Xu W, Rodarte C, Moy AB, Wu MH, Yuan SY. Involvement of ROCK-mediated endothelial tension development in neutrophil-stimulated microvascular leakage. Am J Physiol Heart Circ Physiol. 2006;290:H741-50.
10. Breslin JW, Yuan SY. Involvement of RhoA and Rho kinase in neutrophil-stimulated endothelial hyperpermeability. Am J Physiol Heart Circ Physiol. 2004; 286:H1057-62.
11. Dvorak HF, Nagy JA, Feng D, Brown LF, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr Top Microbiol Immunol. 1999;237:97-132.
12. Tammela T, Enholm B, Alitalo K, Paavonen K. The biology of vascular endothelial growth factors. Cardiovasc Res. 2005;65:550-63.
13. Ferrara N. Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am J Physiol Cell Physiol. 2001;280:C1358-66.
14. Bates DO, Harper SJ. Regulation of vascular permeability by vascular endothelial growth factors. Vascul Pharmacol. 2003;39:225-37.
15. Wu HM, Yuan Y, Zawieja DC, Tinsley J, Granger HJ. Role of phospholipase C, protein kinase C, and calcium in VEGF-induced venular hyperpermeability. Am J Physiol. 1999;276:H535-42.
16. Aramoto H, Breslin JW, Pappas PJ, Hobson RW, 2nd, Duran WN. Vascular endothelial growth factor stimulates differential signaling pathways in in vivo microcirculation. Am J Physiol Heart Circ Physiol. 2004; 287:H1590-8.
17. Hillman NJ, Whittles CE, Pocock TM, Williams B, Bates DO. Differential effects of vascular endothelial growth factor-C and placental growth factor-1 on the hydraulic conductivity of frog mesenteric capillaries. J Vasc Res. 2001;38:176-86.
18. Taipale J, Makinen T, Arighi E, Kukk E, Karkkainen M, Alitalo K. Vascular endothelial growth factor receptor-3. Curr Top Microbiol Immunol. 1999;237:85-96.
19. Karkkainen MJ, Ferrell RE, Lawrence EC, Kimak MA, Levinson KL, McTigue MA, Alitalo K, Finegold DN. Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema. Nat Genet. 2000; 25:153-9.
20. Brice G, Child AH, Evans A, Bell R, Mansour S, Burnand K, Sarfarazi M, Jeffery S, Mortimer P. Milroy disease and the VEGFR-3 mutation phenotype. J Med Genet. 2005;42:98-102.
21. Evans AL, Bell R, Brice G, Comeglio P, Lipede C, Jeffery S, Mortimer P, Sarfarazi M, Child AH. Identification of eight novel VEGFR-3 mutations in families with primary congenital lymphoedema. J Med Genet. 2003;40:697-703.
22. Silha JV, Krsek M, Sucharda P, Murphy LJ. Angiogenic factors are elevated in overweight and obese individuals. Int J Obes (Lond). 2005;29:1308-14.
23. Seyama K, Kumasaka T, Souma S, Sato T, Kurihara M, Mitani K, Tominaga S, Fukuchi Y. Vascular endothelial growth factor-D is increased in serum of patients with lymphangioleiomyomatosis. Lymphat Res Biol. 2006;4:143-52.
24. Mitsuhashi A, Suzuka K, Yamazawa K, Matsui H, Seki K, Sekiya S. Serum vascular endothelial growth factor (VEGF) and VEGF-C levels as tumor markers in patients with cervical carcinoma. Cancer. 2005; 103:724-30.
25. Krzystek-Korpacka M, Matusiewicz M, Diakowska D, Grabowski K, Blachut K, Banas T. Up-regulation of VEGF-C secreted by cancer cells and not VEGF-A correlates with clinical evaluation of lymph node metastasis in esophageal squamous cell carcinoma (ESCC). Cancer Lett. 2006;In Press doi: 10.1016/j.canlet.2006.08.011.
26. Krenn K, Klepetko W, Taghavi S, Lang G, Schneider B, Aharinejad S. Recipient Vascular Endothelial Growth Factor Serum Levels Predict Primary Lung Graft Dysfunction. Am J Transplant. 2007;doi:10.1111/j.1600-6143.2006.01673.x.
27. Marchio S, Primo L, Pagano M, Palestro G, Albini A, Veikkola T, Cascone I, Alitalo K, Bussolino F. Vascular endothelial growth factor-C stimulates the migration and proliferation of Kaposi's sarcoma cells. J Biol Chem. 1999;274:27617-22.
28. Kirkin V, Mazitschek R, Krishnan J, Steffen A, Waltenberger J, Pepper MS, Giannis A, Sleeman JP. Characterization of indolinones which preferentially inhibit VEGF-C- and VEGF-D-induced activation of VEGFR-3 rather than VEGFR-2. Eur J Biochem. 2001; 268:5530-40.
29. Kirkin V, Thiele W, Baumann P, Mazitschek R, Rohde K, Fellbrich G, Weich H, Waltenberger J, Giannis A, Sleeman JP. MAZ51, an indolinone that inhibits endothelial cell and tumor cell growth in vitro, suppresses tumor growth in vivo. Int J Cancer. 2004; 112:986-93.
30. Joukov V, Kumar V, Sorsa T, Arighi E, Weich H, Saksela O, Alitalo K. A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activities. J Biol Chem. 1998;273:6599-602.
31. Moy AB, Blackwell K, Wu MH, Granger HJ. Growth factor- and heparin-dependent regulation of constitutive and agonist-mediated human endothelial barrier function. Am J Physiol Heart Circ Physiol. 2006; 291:H2126-35.
32. Bando H, Brokelmann M, Toi M, Alitalo K, Sleeman JP, Sipos B, Grone HJ, Weich HA. Immunodetection and quantification of vascular endothelial growth factor receptor-3 in human malignant tumor tissues. Int J Cancer. 2004;111:184-91.
33. Pajusola K, Aprelikova O, Pelicci G, Weich H, Claesson-Welsh L, Alitalo K. Signalling properties of FLT4, a proteolytically processed receptor tyrosine kinase related to two VEGF receptors. Oncogene. 1994;9: 3545-55.
34. Mizuno R, Dornyei G, Koller A, Kaley G. Myogenic responses of isolated lymphatics: modulation by endothelium. Microcirculation. 1997;4:413-20.
35. Mizuno R, Koller A, Kaley G. Regulation of the vasomotor activity of lymph microvessels by nitric oxide and prostaglandins. Am J Physiol. 1998;274: R790-6.
36. von der Weid PY, Crowe MJ, Van Helden DF. Endothelium-dependent modulation of pacemaking in lymphatic vessels of the guinea-pig mesentery. J Physiol. 1996;493 (Pt 2):563-75.
37. Gashev AA, Davis MJ, Zawieja DC. Inhibition of the active lymph pump by flow in rat mesenteric lymphatics and thoracic duct. J Physiol. 2002;540:1023-37.
38. Koller A, Mizuno R, Kaley G. Flow reduces the amplitude and increases the frequency of lymphatic vasomotion: role of endothelial prostanoids. Am J Physiol. 1999;277:R1683-9.
39. Ono N, Mizuno R, Ohhashi T. Effective permeability of hydrophilic substances through walls of lymph vessels: roles of endothelial barrier. Am J Physiol Heart Circ Physiol. 2005;289:H1676-82.
40. Yong C, Bridenbaugh EA, Zawieja DC, Swartz MA. Microarray analysis of VEGF-C responsive genes in human lymphatic endothelial cells. Lymphat Res Biol. 2005;3:183-207.